GFAP and neoplasm: Our studies have shown that in both groups, C5b-9 is detected quite frequently on GFAP-positive (tumor-specific) circulating EVs with high VEGF-A expression, whereas C5b-9 was significantly less frequently detected on GFAP-positive EVs with low VEGF-A expression.